Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Granucci

Showing results (111-120 of 115) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 115 results.
Frontiers in Immunology|June 27, 2022
Immunosuppressant Treatment in Rheumatic Musculoskeletal Diseases Does Not Inhibit Elicitation of Humoral Response to SARS-CoV-2 Infection and Preserves Effector Immune Cell PopulationsAndrea Favalli, Ennio Giulio Favalli, Andrea Gobbini, et al.
Nature Communications|July 6, 2026
Dipeptidyl peptidase 3 sets the threshold for immune activation and survival during experimental bacterial infectionAmanda Facoetti, Luca Lambroia, Elena Fontana, et al.
Science Immunology|August 11, 2021
Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patientsSamuele Notarbartolo, Valeria Ranzani, Alessandra Bandera, et al.
Immunome Research|November 25, 2010
DC-ATLAS: a systems biology resource to dissect receptor specific signal transduction in dendritic cellsDuccio Cavalieri, Damariz Rivero, Luca Beltrame, et al.
Nature Genetics|September 2, 2004
The European dimension for the mouse genome mutagenesis programJohan Auwerx, Phil Avner, Richard Baldock, et al.
Pageof 12

Showing results (111-120 of 115) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 115 results.
Frontiers in Immunology|June 27, 2022
Immunosuppressant Treatment in Rheumatic Musculoskeletal Diseases Does Not Inhibit Elicitation of Humoral Response to SARS-CoV-2 Infection and Preserves Effector Immune Cell PopulationsAndrea Favalli, Ennio Giulio Favalli, Andrea Gobbini, et al.
Nature Communications|July 6, 2026
Dipeptidyl peptidase 3 sets the threshold for immune activation and survival during experimental bacterial infectionAmanda Facoetti, Luca Lambroia, Elena Fontana, et al.
Science Immunology|August 11, 2021
Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patientsSamuele Notarbartolo, Valeria Ranzani, Alessandra Bandera, et al.
Immunome Research|November 25, 2010
DC-ATLAS: a systems biology resource to dissect receptor specific signal transduction in dendritic cellsDuccio Cavalieri, Damariz Rivero, Luca Beltrame, et al.
Nature Genetics|September 2, 2004
The European dimension for the mouse genome mutagenesis programJohan Auwerx, Phil Avner, Richard Baldock, et al.
Pageof 12